Technical Note—Stochastic Scheduling with Abandonment: Necessary and Sufficient Conditions for the Optimality of a Strict Priority Policy
Operations Research · 2023-09 · 71 (5) · 1789-1793
DOI: 10.1287/opre.2022.2285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Operations Research, 2023-09. Verfasst von Gang Chen und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Strict priority policies in a stochastic system with abandonment In the technical note “Stochastic scheduling with abandonment: Necessary and sufficient conditions for the optimality of a strict priority policy,” Chen, Gayon, and Lemaire consider a stochastic scheduling problem in which jobs abandon when their waiting time exceeds their lifetime. Such a problem arises, for example, in call centers or emergency systems. It is known that the optimal policy is a strict priority policy under some sets of conditions. The authors provide the first set of necessary and sufficient conditions for a problem with two types of jobs. They also provide conjectures to guide toward generalizations of the proposed conditions.
Zitieren
APA
Chen, G., Gayon, J., & Lemaire, P. (2023). Technical Note—Stochastic Scheduling with Abandonment: Necessary and Sufficient Conditions for the Optimality of a Strict Priority Policy. Operations Research, 71(5), 1789-1793. https://doi.org/10.1287/opre.2022.2285
Vancouver
Chen G, Gayon J, Lemaire P. Technical Note—Stochastic Scheduling with Abandonment: Necessary and Sufficient Conditions for the Optimality of a Strict Priority Policy. Operations Research. 2023;71(5):1789-1793. doi:10.1287/opre.2022.2285
BibTeX
@article{Chen2023,
author = {Chen, Gang and Gayon, Jean-Philippe and Lemaire, Pierre},
title = {Technical Note—Stochastic Scheduling with Abandonment: Necessary and Sufficient Conditions for the Optimality of a Strict Priority Policy},
journal = {Operations Research},
year = {2023},
volume = {71},
number = {5},
pages = {1789--1793},
doi = {10.1287/opre.2022.2285}
}
EUVIMED